Pfizer is already active in the protein degrader area, having partnered with Arvinas in a $2 billion-plus deal signed in 2021 focusing on vepdegestrant (ARV-471), an orally active selective oestrogen ...

The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it acquired Novartis' global vaccine business in 2015. Only by tapping into ...

Long-term considerations: While short-term forecasting remains a priority, forecasters also keep an eye on medium and ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

Drilling down into the reasons behind that upward trend, all three purchaser groups reported increased consumer demand (83%) ...

Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic ...

It is Transgene's second most advanced neoantigen immunotherapy programme after TG4050 for head and neck cancer, which is in ...

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an ...

The proposal, unveiled at the government's International Investment Summit today is headlined by the creation of a UK biotech ...

In our final video from ESMO 2024, web editor Nicole Raleigh spoke with Dr Meredith McKean, a melanoma investigator at the Sarah Cannon Research Institute.

To encourage the uptake of complex therapies in clinical practice, brand teams must ensure they use data-driven insights to ...

With ever more life sciences graduates coming on stream, job seekers also need to get creative to land their ideal role in ...